Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies

Prenatal Diagnosis

Volumn 24, Issue 3, 2004, Pages 224-226

  Wallace, Euan M ^a   Marjono, Budi ^a   Brown, David A ^b   Crossley, Jennifer ^c   Tong, Stephen ^a   Aitken, David ^c   Breit, Sam ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Medical Genetics   (United Kingdom)

Author keywords

Amniotic fluid; Down syndrome; Macrophage inhibitory cytokine 1; Pregnancy

Indexed keywords

CYTOKINE; MACROPHAGE INHIBITORY CYTOKINE 1; UNCLASSIFIED DRUG;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AMNIOTIC FLUID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DOWN SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY;

EID: 1842428722     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.791     Document Type: Article

References (21)

1. Aitken DA, Wallace EM, Crossley JA, et al. 1996. Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy. N Eng J Med 334: 1321-1326.
2. Bootcov MR, Bauskin AR, Valenzuela SM, et al. 1997. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc Nat Acad Sci USA 94: 11 514-11 519.
3. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K. 1999. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297: 103-110.
4. Brown DA, Bauskin AR, Fairlie WD, et al. 2002a. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 33: 118-120.
5. Brown DA, Breit SN, Buring J, et al. 2002b. Plasma concentration of macrophage inhibitory cytokine-1 (MIC-1) and the risk of cardiovascular events in women: a nested case-control study. Lancet 359: 2159-2163.
6. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. 1999. Inhibition of TGF-b3 restores the invasive capability of extravillous trophoblasts in pre-eclamptic pregnancies. J Clin Invest 103: 1641-1650.
7. Caniggia I, Lye SJ, Cross JC. 1997. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinol 138: 3976-3986.
8. Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. 1995. Maternal serum dimeric inhibin-A in second trimester Down's syndrome pregnancies. Prenat Diagn 15: 385-386.
9. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. 1999. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65: 2-5.
10. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. 1998. A longitudinal study of maternal serum inhibin A, inhibin B, activin A, activin AB, pro-aC and follistatin during pregnancy. Hum Reprod 13: 3530-3536.
11. Lawton LN, Bonaldo MF, Jelenc PC, et al. 1997. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 23: 17-26.
12. Marjono AB, Brown DA, Horton KE, Wallace EM, Breit SN, Mannelpillai U. 2003. Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta 24: 100-106.
13. Moore AG, Brown DA, Fairlie WD, et al. 2000. The transforming growth factor-beta superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 85: 4781-4788.
14. Paralkar VM, Vail AL, Grasser WA, et al. 1998. Cloning and characterization of a novel member of the transforming growth factor-β/ bone morphogenetic protein family. J Biol Chem 273: 13 760-13 767.
15. Schneider-Kolsky M, D'Antona D, Evans LW, et al. 2000. Maternal serum total activin A and follistatin in pregnancy and parturition. BJOG 107: 995-1000.
16. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A, Wallace EM. 2002. The distribution of activin and activin receptors in gestational tissues across pregnancy. Placenta 23: 294-302.
17. Strelau J, Sullivan A, Bottner M, et al. 2000. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 20: 8597-8603.
18. Wallace EM. 1999. Inhibins, activins and follistatin in amniotic fluid in normal and Down syndrome pregnancies. In Amniotic Fluid, Rao KA, Ross MG (eds). Prism Books Pvt Ltd: Bangalore; 41-51.
19. Wallace EM, Crossley JA, Groome NP, Aitken DA. 1997. Inhibin-A in amniotic fluid in chromosomally normal and Down's syndrome pregnancies. J Endocrinol 152: 109-112.
20. Wallace EM, D'Antona D, Shearing C, et al. 1999. Amniotic fluid levels of dimeric inhibins, pro-aC inhibin, activin A and follistatin in Down syndrome. Clin Endocrinol 50: 669-673.
21. Wallace EM, Swanston IA, Groome NP. 1995. Evaluation of maternal serum dimeric inhibin A as a first trimester marker of Down's syndrome. Prenat Diagn 15: 359-362.